<p>Organ transplant patients are concerned the drugs they take to survive can cause other health problems like cancer and diabetes, and yet the medications haven’t improved in decades. Why has drug development in transplantation been stalled?</p>

Organ transplant patients are concerned the drugs they take to survive can cause other health problems like cancer and diabetes, and yet the medications haven’t improved in decades. Why has drug development in transplantation been stalled?

Has drug development in transplantation been stymied?

Hosted by Meghna Chakrabarti, On Point is a unique, curiosity-driven combination of original reporting, newsmaker interviews, first-person stories, and in-depth analysis, making the world more intelligible and humane. When the world is more complicated than ever, we aim to make sense of it together. On Point is produced by WBUR.

Share Has drug development in transplantation been stymied?

Sign up to save your podcasts

Has drug development in transplantation been stymied?

Has drug development in transplantation been stymied?

More shows like On Point | Podcast

Science Friday

On the Media

KERA's Think

Diane Rehm: On My Mind

Fresh Air

The Political Scene | The New Yorker

Here & Now Anytime

Dear Sugars

Hidden Brain

The New Yorker Radio Hour

The NPR Politics Podcast

1A

Circle Round

Radio Atlantic

Endless Thread

Last Seen

Interesting Times with Ross Douthat

Throughline

Anything For Selena

The Ezra Klein Show

Short Run

The Common

Beyond All Repair